Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

Hundreds of a people who have chronic liver disease are being helped by an NHS trust's service that helps them attend vital ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new ...

Hepatocellular carcinoma (HCC) is an aggressive disease that accounts for 80%-90% of all primary liver cancers. Previous findings have shown fibroblast growth factor 19 (FGF-19) to be overexpressed in ...

Abstract and Introduction Risk Factors for HCC in the Absence of HBV or HCV Infection Prevention of Nonviral Liver Disease-related HCC References In summary, HCC is unusual among common human ...

Hepatobiliary cancers, which include biliary tract cancer (BTC) and hepatocellular carcinoma (HCC), are among the most lethal ...

Addition of the anti-TIGIT monoclonal antibody tiragolumab to standard first-line treatment resulted in better response rates and improved survival for patients with unresectable hepatocellular ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.